United Kingdom

Taiyo Holdings Co Ltd (4626.T)

4626.T on Tokyo Stock Exchange

23 Mar 2018
Change (% chg)

¥-50 (-1.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Marketing and manufacturing right transfer of 13 long-term listed products from Chugai Pharmaceutical to Taiyo Pharma
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says it and TAIYO HOLDINGS CO LTD <<<4626.T>>> announced today that they have entered into an agreement, under which the co and F. Hoffmann-La Roche, Ltd. will transfer the marketing authorizations, including marketing and manufacturing rights, of 13 long-term listed products manufactured and marketed in Japan by Chugai to TAIYO Pharma Co., Ltd., a wholly owned subsidiary of Taiyo Holdings.  Full Article

Taiyo Holdings completes private placement for 153.8 mln yen
Monday, 27 Jun 2016 

Taiyo Holdings Co Ltd <4626.T> :Says it completes 42,900 shares issuance via private placement and raises about 153.8 million yen in total, on June 27.  Full Article

Taiyo Holdings to issue preferred shares at 153.8 mln yen
Friday, 27 May 2016 

Taiyo Holdings Co Ltd <4626.T>:Says it to issue 42,900 class A preferred shares at 3,585 yen per share (153.8 million yen in total), through private placement to five individuals, on June 27.  Full Article

Roche's Chugai transfers rights of 13 Long-Term Listed Products to Taiyo

ZURICH, Nov 14 Chugai Pharmaceuticals, a Japan-based Roche subsidiary, said on Tuesday it has agreed to transfer the marketing and manufacturing right of 13 long-term listed products to Taiyo Holdings' Taiyo Pharma.